Cargando…

Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study

BACKGROUND: We investigated the effect of longitudinal status change in metabolic syndrome (MetS) assessed by two different criteria on new onset of type 2 diabetes (NODM) in a Japanese population. METHODS: The participants were 827 non-diabetic citizens who had undergone medical examinations in 199...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnishi, Hirofumi, Saitoh, Shigeyuki, Akasaka, Hiroshi, Furukawa, Tetsuaki, Mori, Mitsuru, Miura, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011865/
https://www.ncbi.nlm.nih.gov/pubmed/27602060
http://dx.doi.org/10.1186/s13098-016-0182-0
_version_ 1782451909088509952
author Ohnishi, Hirofumi
Saitoh, Shigeyuki
Akasaka, Hiroshi
Furukawa, Tetsuaki
Mori, Mitsuru
Miura, Tetsuji
author_facet Ohnishi, Hirofumi
Saitoh, Shigeyuki
Akasaka, Hiroshi
Furukawa, Tetsuaki
Mori, Mitsuru
Miura, Tetsuji
author_sort Ohnishi, Hirofumi
collection PubMed
description BACKGROUND: We investigated the effect of longitudinal status change in metabolic syndrome (MetS) assessed by two different criteria on new onset of type 2 diabetes (NODM) in a Japanese population. METHODS: The participants were 827 non-diabetic citizens who had undergone medical examinations in 1994 and 2003 or 2004. We used two different criteria of MetS: the interim criteria by 6 institutions (MetS-INT) and Japanese criteria (MetS-JP). According to the interim criteria, individuals defined as having MetS have any three of the following five components of MetS: obesity, hyperglycemia, high blood pressure, hypertriglyceridemia and low HDL cholesterolemia. According to the Japanese criteria, individuals defined as having MetS must have abdominal obesity plus any two of the following three factors; hyperglycemia, high blood pressure and dyslipidemia (hypertriglyceridemia and/or low HDL-cholesterolemia). According to the status change in MetS, participants were divided into four groups: a non-MetS to non-MetS group, a non-MetS to MetS group, a MetS to non-MetS group and a MetS to MetS group. We calculated odds ratios of these four groups for NODM. RESULTS: NODM occurred in 65 participants. The odds ratios for NODM were 4.86, 4.97 and 7.50 in the non-MetS-INT to MetS-INT group, MetS-INT to non-MetS-INT group and MetS-INT to MetS-INT group, respectively. On the other hand, the odds ratios were 4.28 and 15.55 in the non-MetS-JP to MetS-JP group and MetS-JP to MetS-JP group, respectively. After adjustment for high fasting plasma glucose at baseline, magnitude of the odds ratio of MetS to MetS group was larger in the Japanese criteria group than in the interim criteria group. CONCLUSIONS: Determining the status of MetS routinely and paying attention to status change in MetS may be important for prevention of type 2 diabetes. MetS defined by the criteria which includes obesity as a prerequisite component may be a stronger risk for type 2 diabetes than MetS defined by the criteria which includes obesity as one of components.
format Online
Article
Text
id pubmed-5011865
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50118652016-09-07 Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study Ohnishi, Hirofumi Saitoh, Shigeyuki Akasaka, Hiroshi Furukawa, Tetsuaki Mori, Mitsuru Miura, Tetsuji Diabetol Metab Syndr Research BACKGROUND: We investigated the effect of longitudinal status change in metabolic syndrome (MetS) assessed by two different criteria on new onset of type 2 diabetes (NODM) in a Japanese population. METHODS: The participants were 827 non-diabetic citizens who had undergone medical examinations in 1994 and 2003 or 2004. We used two different criteria of MetS: the interim criteria by 6 institutions (MetS-INT) and Japanese criteria (MetS-JP). According to the interim criteria, individuals defined as having MetS have any three of the following five components of MetS: obesity, hyperglycemia, high blood pressure, hypertriglyceridemia and low HDL cholesterolemia. According to the Japanese criteria, individuals defined as having MetS must have abdominal obesity plus any two of the following three factors; hyperglycemia, high blood pressure and dyslipidemia (hypertriglyceridemia and/or low HDL-cholesterolemia). According to the status change in MetS, participants were divided into four groups: a non-MetS to non-MetS group, a non-MetS to MetS group, a MetS to non-MetS group and a MetS to MetS group. We calculated odds ratios of these four groups for NODM. RESULTS: NODM occurred in 65 participants. The odds ratios for NODM were 4.86, 4.97 and 7.50 in the non-MetS-INT to MetS-INT group, MetS-INT to non-MetS-INT group and MetS-INT to MetS-INT group, respectively. On the other hand, the odds ratios were 4.28 and 15.55 in the non-MetS-JP to MetS-JP group and MetS-JP to MetS-JP group, respectively. After adjustment for high fasting plasma glucose at baseline, magnitude of the odds ratio of MetS to MetS group was larger in the Japanese criteria group than in the interim criteria group. CONCLUSIONS: Determining the status of MetS routinely and paying attention to status change in MetS may be important for prevention of type 2 diabetes. MetS defined by the criteria which includes obesity as a prerequisite component may be a stronger risk for type 2 diabetes than MetS defined by the criteria which includes obesity as one of components. BioMed Central 2016-09-05 /pmc/articles/PMC5011865/ /pubmed/27602060 http://dx.doi.org/10.1186/s13098-016-0182-0 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ohnishi, Hirofumi
Saitoh, Shigeyuki
Akasaka, Hiroshi
Furukawa, Tetsuaki
Mori, Mitsuru
Miura, Tetsuji
Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study
title Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study
title_full Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study
title_fullStr Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study
title_full_unstemmed Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study
title_short Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno–Sobetsu Study
title_sort impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general japanese population: the tanno–sobetsu study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011865/
https://www.ncbi.nlm.nih.gov/pubmed/27602060
http://dx.doi.org/10.1186/s13098-016-0182-0
work_keys_str_mv AT ohnishihirofumi impactoflongitudinalstatuschangeinmetabolicsyndromedefinedbytwodifferentcriteriaonnewonsetoftype2diabetesinageneraljapanesepopulationthetannosobetsustudy
AT saitohshigeyuki impactoflongitudinalstatuschangeinmetabolicsyndromedefinedbytwodifferentcriteriaonnewonsetoftype2diabetesinageneraljapanesepopulationthetannosobetsustudy
AT akasakahiroshi impactoflongitudinalstatuschangeinmetabolicsyndromedefinedbytwodifferentcriteriaonnewonsetoftype2diabetesinageneraljapanesepopulationthetannosobetsustudy
AT furukawatetsuaki impactoflongitudinalstatuschangeinmetabolicsyndromedefinedbytwodifferentcriteriaonnewonsetoftype2diabetesinageneraljapanesepopulationthetannosobetsustudy
AT morimitsuru impactoflongitudinalstatuschangeinmetabolicsyndromedefinedbytwodifferentcriteriaonnewonsetoftype2diabetesinageneraljapanesepopulationthetannosobetsustudy
AT miuratetsuji impactoflongitudinalstatuschangeinmetabolicsyndromedefinedbytwodifferentcriteriaonnewonsetoftype2diabetesinageneraljapanesepopulationthetannosobetsustudy